Related Experiment Video
Updated: Mar 17, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Risk prevention in patients on antithrombotic therapy for common oral invasive treatment]
1Medical Center of Stomatology, Beijing An Zhen Hospital, Capital Medical University, Beijing 100029, China.
Abstract:
The high incidence of cardiovascular diseases makes the dentists have more chance to treat patients who receive antithrombotic therapy. Limited by the profession, many dentists are unfamiliar with the systemic disease that the patients suffer from, especially struggle with whether or not to stop the antithrombotic therapy before the invasive diagnosis and treatment such as tooth extraction, dental implant placement and periodontal treatment. Stopping antithrombotic drugs may lead to thrombosis risk, while sustaining antithrombotic drug treatment may lead to bleeding risk. Through literature review and the experience of oral diagnosis and treatment of patients with cardiovascular diseases in our department for many years, the author aims to discuss preventive measures of bleeding and thrombosis risk of patients with oral antithrombotic therapy in oral invasive diagnosis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Tonsillitis II: Management

